Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297.
Int. J. Radiat. Oncol. Biol. Phys., Sep;72(1):108-13 (2008)
Postoperative mortality after esophagectomy for cancer: development of a preoperative risk prediction model.
Ann. Surg. Oncol., Jun;15(6):1577-84 (2008)
Time of day is associated with postoperative morbidity: an analysis of the national surgical quality improvement program data.
Ann. Surg., Mar;247(3):544-52 (2008)
Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
J. Clin. Oncol., Mar;25(9):1129-34 (2007)
Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion.
Cancer Res., Feb;67(4):1842-52 (2007)
Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patients.
Ann. Surg. Oncol., May;14(5):1596-603 (2007)
HIV protease inhibitor nelfinavir inhibits growth of human melanoma cells by induction of cell cycle arrest.
Cancer Res., Feb;67(3):1221-7 (2007)
Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.
Cancer., Nov;107(10):2436-45 (2006)
Preferential involvement of CX chemokine receptor 4 and CX chemokine ligand 12 in T-cell migration toward melanoma cells.
Cancer Biol. Ther., Oct;5(10):1304-12 (2006)
Use of radiotracer for sentinel lymph node mapping in breast cancer optimizes staging independent of site of administration.
Clin Nucl Med., Sep;31(9):527-33 (2006)
Predictors of regional nodal disease in patients with thin melanomas.
Ann. Surg. Oncol., Apr;13(4):533-41 (2006)
Should all melanoma patients undergo sentinel lymph node biopsy?
Curr Opin Oncol., Mar;18(2):185-8 (2006)
AKT activation and response to interferon-beta in human cancer cells.
Cancer Biol. Ther., Jul;4(7):709-15 (2005)
Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.
Ann. Surg. Oncol., Jun;12(6):449-58 (2005)
Combined 5-fluorouracil/systemic interferon-beta gene therapy results in long-term survival in mice with established colorectal liver metastases.
Clin. Cancer Res., Feb;10(4):1535-44 (2004)
Gene therapy for cancer and metastatic disease.
Expert Rev Mol Med., Jun;5(17):1-18 (2003)
Stat1-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand and the cell-surface death signaling pathway by interferon beta in human cancer cells.
Cancer Res., Sep;63(17):5299-307 (2003)
p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer.
Clin. Cancer Res., Oct;3(10):1685-90 (1997)
Viral and nonviral gene delivery vectors for cancer gene therapy.
Cancer Detect. Prev., 22(5):445-54 (1998)
Hemangiopericytoma: a 20-year single-institution experience.
Ann. Surg. Oncol., Jun;5(4):350-5 (1998)
Primary pancreatic lymphoma.
Surgery., Apr;123(4):382-90 (1998)
Role of conservation therapy for invasive lobular carcinoma of the breast.
Ann. Surg. Oncol., Dec;4(8):650-4 (1997)
Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.
J. Clin. Oncol., Mar;15(3):928-37 (1997)
In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer.
Anticancer Res., 16(6B):3415-22 (1996 Nov-Dec)
Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer.
J. Thorac. Cardiovasc. Surg., Nov;112(5):1372-6; discussion 1376-7 (1996)
Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation.
Clin. Cancer Res., Oct;2(10):1665-71 (1996)
High levels of gene transduction in human lung tumors following intralesional injection of recombinant adenovirus.
Cancer Gene Ther., 3(4):245-9 (1996 Jul-Aug)